Translate Bio, Inc. (32) | Human Resources (15)

Browse by Subcategory

Recent Contracts

Consulting Agreement, dated June 16, 2021, by and between the Registrant and Daniel Lynch (Filed With SEC on August 5, 2021)
Second Amended and Restated Director Compensation Plan, adopted June 16, 2021 (Filed With SEC on August 5, 2021)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between Registrant and Ann Barbier (Filed With SEC on May 6, 2021)
Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (No Acceleration) (Filed With SEC on March 1, 2021)
Separation Agreement, dated December 27, 2020, by and between the Registrant and John R. Schroer (Filed With SEC on March 1, 2021)
First Amendment, dated September 22, 2020 to Suite Retention and Development Agreement, dated September 9, 2019, by and between Albany Molecular Research, Inc. and the Registrant (Filed With SEC on November 5, 2020)
First Amended and Restated Director Compensation Plan, adopted March 9, 2021 (Filed With SEC on May 6, 2021)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between Registrant and Paul Burgess (Filed With SEC on May 6, 2021)
2021 Inducement Stock Incentive Plan (Filed With SEC on March 1, 2021)
Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (Double Trigger Acceleration) (Filed With SEC on March 1, 2021)
Form of Stock Option Agreement under the 2021 Inducement Stock Incentive Plan (Single Trigger Acceleration) (Filed With SEC on March 1, 2021)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and Brian Fenton (Filed With SEC on March 12, 2020)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and John R. Schroer (Filed With SEC on March 12, 2020)
Amended and Restated Employment Agreement, dated March 11, 2020, by and between the Registrant and Richard Wooster (Filed With SEC on March 12, 2020)
Suite Retention and Development Agreement, dated September 9, 2019, by and between Albany Molecular Research Inc. and the Registrant (Filed With SEC on November 6, 2019)